| scholarly article | Q13442814 |
| P2093 | author name string | Kobayashi K | |
| Oka K | |||
| Siest G | |||
| Chan L | |||
| Havekes LM | |||
| Hofker MH | |||
| van Dijk KW | |||
| Jong MC | |||
| Dahlmans VE | |||
| Van der Boom H | |||
| P2860 | cites work | Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein | Q41709963 |
| Synthesis and properties of the very-low-density-lipoprotein receptor and a comparison with the low-density-lipoprotein receptor | Q41970201 | ||
| Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice | Q41995314 | ||
| Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23. | Q42805194 | ||
| The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations | Q43819349 | ||
| Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene | Q45877135 | ||
| Expression of the VLDL receptor in endothelial cells | Q49101801 | ||
| Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor | Q64382900 | ||
| Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein | Q68819183 | ||
| The effect of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat | Q70603231 | ||
| Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1 | Q71231776 | ||
| VLDL receptor mediates the uptake of human chylomicron remnants in vitro | Q71670700 | ||
| Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and E | Q71843149 | ||
| Effect of apolipoprotein C-I peptides on the apolipoprotein E content and receptor-binding properties of beta-migrating very low density lipoproteins | Q72317459 | ||
| Bone marrow transplantation in apolipoprotein E-deficient mice. Effect of ApoE gene dosage on serum lipid concentrations, (beta)VLDL catabolism, and atherosclerosis | Q73965942 | ||
| Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor | Q74100225 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity | Q24293268 | ||
| Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver | Q24300330 | ||
| The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor | Q24319741 | ||
| Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway | Q24323234 | ||
| Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants | Q24564846 | ||
| Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery | Q29615235 | ||
| Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor | Q33982023 | ||
| Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors | Q34263181 | ||
| Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice | Q36201407 | ||
| Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl | Q37358494 | ||
| In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway | Q37361432 | ||
| Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. | Q37376984 | ||
| Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages | Q41222701 | ||
| Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase | Q41333469 | ||
| Very low density lipoprotein receptor from mammary gland and mammary epithelial cell lines binds and mediates endocytosis of M(r) 40,000 receptor associated protein | Q41429335 | ||
| Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. | Q41493690 | ||
| Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors | Q41571853 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| Adenoviridae | Q193447 | ||
| hyperlipidemia | Q1079120 | ||
| P304 | page(s) | 281-287 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor | |
| P478 | volume | 338 ( Pt 2) |
| Q37222426 | ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans |
| Q36294705 | Apolipoprotein C-I Levels Are Associated with the Urinary Protein/Urinary Creatinine Ratio in Pediatric Idiopathic Steroid-Sensitive Nephrotic Syndrome: A Case Control Study |
| Q92861943 | Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer |
| Q37299858 | Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma. |
| Q41825540 | Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice |
| Q48315712 | Apolipoproteins E and C1 and brain morphology in memory impaired elders. |
| Q48217772 | Cloning and spatiotemporal expression of Xenopus laevis Apolipoprotein CI. |
| Q33926011 | Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice. |
| Q33519546 | Identifying blood biomarkers and physiological processes that distinguish humans with superior performance under psychological stress |
| Q73668740 | Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism |
| Q36930204 | WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects |
Search more.